Latest Insider Transactions at Intercept Pharmaceuticals, Inc. (ICPT)
This section provides a real-time view of insider transactions for Intercept Pharmaceuticals, Inc. (ICPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERCEPT PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERCEPT PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2021
|
Fundaro Paolo Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+20.03%
|
-
|
|
May 27
2021
|
Keith Michael Gottesdiener Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+29.27%
|
-
|
|
May 27
2021
|
Nancy Miller Rich Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+32.55%
|
-
|
|
May 27
2021
|
Gino Santini Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+30.64%
|
-
|
|
May 27
2021
|
Glenn Sblendorio Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,029
+30.91%
|
-
|
|
May 15
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
171
-0.64%
|
$3,078
$18.15 P/Share
|
|
May 12
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.97%
|
$5,423
$17.75 P/Share
|
|
May 08
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.54%
|
$2,176
$17.15 P/Share
|
|
Apr 30
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,817
-0.75%
|
$72,523
$19.78 P/Share
|
|
Apr 30
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+1.2%
|
$116,622
$19.78 P/Share
|
|
Apr 01
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.35%
|
$6,936
$24.28 P/Share
|
|
Apr 01
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.38%
|
$2,208
$24.28 P/Share
|
|
Apr 01
2021
|
Rocco Venezia Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29
-0.2%
|
$696
$24.28 P/Share
|
|
Apr 01
2021
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.17%
|
$1,104
$24.28 P/Share
|
|
Mar 31
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,658
-0.73%
|
$84,134
$23.08 P/Share
|
|
Mar 31
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,136
+1.2%
|
$141,128
$23.08 P/Share
|
|
Mar 12
2021
|
Srinivas Akkaraju Director |
BUY
Open market or private purchase
|
Indirect |
147,000
+18.66%
|
$3,087,000
$21.29 P/Share
|
|
Mar 10
2021
|
Srinivas Akkaraju Director |
BUY
Open market or private purchase
|
Indirect |
90,000
+8.29%
|
$1,890,000
$21.19 P/Share
|
|
Feb 27
2021
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-1.29%
|
$7,497
$21.66 P/Share
|
|
Feb 26
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,741
-0.55%
|
$57,561
$21.66 P/Share
|
|
Feb 26
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+1.21%
|
$128,898
$21.66 P/Share
|
|
Feb 23
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.39%
|
$8,932
$28.12 P/Share
|
|
Feb 15
2021
|
Linda M Richardson EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,531
+17.07%
|
-
|
|
Feb 12
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.96%
|
$9,889
$31.32 P/Share
|
|
Feb 08
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
148
-0.61%
|
$5,328
$36.04 P/Share
|
|
Feb 01
2021
|
Jared Freedberg General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
44,277
+50.0%
|
-
|
|
Jan 29
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,741
-0.55%
|
$95,935
$35.24 P/Share
|
|
Jan 29
2021
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,138
+1.22%
|
$214,830
$35.24 P/Share
|
|
Jan 22
2021
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+27.52%
|
-
|
|
Jan 22
2021
|
Jerome Benedict Durso CEO |
BUY
Grant, award, or other acquisition
|
Direct |
46,000
+35.73%
|
-
|
|
Jan 22
2021
|
Jason Campagna Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+38.03%
|
-
|
|
Jan 22
2021
|
David A Ford Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,500
+32.32%
|
-
|
|
Jan 22
2021
|
Sandip Kapadia CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
17,200
+29.57%
|
-
|
|
Jan 22
2021
|
Christian Weyer EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
12,600
+31.23%
|
-
|
|
Jan 11
2021
|
Bryan Ball Chief Qual. Officer & SVP Ops. |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
-
|
|
Jan 05
2021
|
Sandip Kapadia CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
2,193
-8.45%
|
$52,632
$24.47 P/Share
|
|
Jan 01
2021
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
334
-0.9%
|
$8,016
$24.7 P/Share
|
|
Jan 01
2021
|
Jason Campagna Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-1.64%
|
$3,168
$24.7 P/Share
|
|
Jan 01
2021
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.84%
|
$2,544
$24.7 P/Share
|
|
Jan 01
2021
|
Sandip Kapadia CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
342
-1.3%
|
$8,208
$24.7 P/Share
|
|
Jan 01
2021
|
Richard J Kim President US Comm & Strat Mktg |
SELL
Payment of exercise price or tax liability
|
Direct |
259
-1.29%
|
$6,216
$24.7 P/Share
|
|
Jan 01
2021
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
632
-0.13%
|
$15,168
$24.7 P/Share
|
|
Jan 01
2021
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-0.36%
|
$1,296
$24.7 P/Share
|
|
Dec 31
2020
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-3.32%
|
$16,944
$24.7 P/Share
|
|
Dec 31
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-4.38%
|
$40,800
$24.7 P/Share
|
|
Dec 31
2020
|
Jason Campagna Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
534
-6.21%
|
$12,816
$24.7 P/Share
|
|
Dec 31
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
629
-4.72%
|
$15,096
$24.7 P/Share
|
|
Dec 31
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-3.16%
|
$20,616
$24.7 P/Share
|
|
Dec 31
2020
|
Richard J Kim President US Comm & Strat Mktg |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-3.84%
|
$19,176
$24.7 P/Share
|
|
Dec 31
2020
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25,065
-4.85%
|
$601,560
$24.7 P/Share
|